FI981337A0 - Method for preparing virus-safe pharmaceutical compositions - Google Patents
Method for preparing virus-safe pharmaceutical compositionsInfo
- Publication number
- FI981337A0 FI981337A0 FI981337A FI981337A FI981337A0 FI 981337 A0 FI981337 A0 FI 981337A0 FI 981337 A FI981337 A FI 981337A FI 981337 A FI981337 A FI 981337A FI 981337 A0 FI981337 A0 FI 981337A0
- Authority
- FI
- Finland
- Prior art keywords
- pharmaceutical compositions
- safe pharmaceutical
- preparing virus
- virus
- preparing
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P21/00—Preparation of peptides or proteins
- C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/21—Interferons [IFN]
- A61K38/212—IFN-alpha
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
- A61L2/0005—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts
- A61L2/0011—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts using physical methods
- A61L2/0017—Filtration
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/14—Extraction; Separation; Purification
- C07K1/34—Extraction; Separation; Purification by filtration, ultrafiltration or reverse osmosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/555—Interferons [IFN]
- C07K14/56—IFN-alpha
Priority Applications (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FI981337A FI106465B (en) | 1998-06-10 | 1998-06-10 | A process for preparing virus-safe pharmaceutical compositions |
AU47834/99A AU4783499A (en) | 1998-06-10 | 1999-06-09 | Method for preparing virus-safe pharmaceutical compositions |
PCT/FI1999/000505 WO1999064441A1 (en) | 1998-06-10 | 1999-06-09 | Method for preparing virus-safe pharmaceutical compositions |
EP99931279A EP1086120A1 (en) | 1998-06-10 | 1999-06-09 | Method for preparing virus-safe pharmaceutical compositions |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FI981337A FI106465B (en) | 1998-06-10 | 1998-06-10 | A process for preparing virus-safe pharmaceutical compositions |
FI981337 | 1998-06-10 |
Publications (3)
Publication Number | Publication Date |
---|---|
FI981337A0 true FI981337A0 (en) | 1998-06-10 |
FI981337A FI981337A (en) | 1999-12-11 |
FI106465B FI106465B (en) | 2001-02-15 |
Family
ID=8551961
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FI981337A FI106465B (en) | 1998-06-10 | 1998-06-10 | A process for preparing virus-safe pharmaceutical compositions |
Country Status (4)
Country | Link |
---|---|
EP (1) | EP1086120A1 (en) |
AU (1) | AU4783499A (en) |
FI (1) | FI106465B (en) |
WO (1) | WO1999064441A1 (en) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE10211632A1 (en) * | 2002-03-15 | 2003-10-09 | Aventis Behring Gmbh | Process for the separation of viruses from a protein solution by nanofiltration |
ITMI20031940A1 (en) * | 2003-10-09 | 2005-04-10 | Prodotti Chimici Alimentari | METHOD FOR FELLING THE INFECTIOUS AGENTS OF TSE IN BILE AND DERIVATIVES |
ES2926359T3 (en) | 2003-12-01 | 2022-10-25 | Novo Nordisk Healthcare Ag | Virus filtration of liquid Factor VII compositions |
WO2007017242A2 (en) * | 2005-08-08 | 2007-02-15 | Csl Behring Gmbh | Novel virus reduction method based on detergents and shearing forces |
CA2823005C (en) | 2010-12-30 | 2019-07-09 | Laboratoire Francais Du Fractionnement Et Des Biotechnologies | Glycols as pathogen inactivating agents |
KR102316263B1 (en) | 2017-06-12 | 2021-10-26 | 아사히 가세이 메디컬 가부시키가이샤 | Filtration method of protein-containing liquid |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4680175A (en) * | 1984-02-07 | 1987-07-14 | Interferon Sciences, Inc. | Interferon administration vehicles |
DE3603444A1 (en) * | 1986-02-05 | 1987-08-06 | Thomae Gmbh Dr K | PHARMACEUTICAL PREPARATIONS FOR STABILIZING INTERFERON ALPHA |
DE4217335C2 (en) * | 1992-05-26 | 1996-01-18 | Seitz Filter Werke | Hydrophilic membrane and process for its manufacture |
-
1998
- 1998-06-10 FI FI981337A patent/FI106465B/en active
-
1999
- 1999-06-09 WO PCT/FI1999/000505 patent/WO1999064441A1/en not_active Application Discontinuation
- 1999-06-09 AU AU47834/99A patent/AU4783499A/en not_active Abandoned
- 1999-06-09 EP EP99931279A patent/EP1086120A1/en not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
AU4783499A (en) | 1999-12-30 |
EP1086120A1 (en) | 2001-03-28 |
FI106465B (en) | 2001-02-15 |
FI981337A (en) | 1999-12-11 |
WO1999064441A1 (en) | 1999-12-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EA199900373A3 (en) | PHARMACEUTICAL COMPOSITIONS | |
ID22891A (en) | PHARMACEUTICAL COMPOSITION FOR PIPERIDINOALANOL-DECONGESTANT COMBINATIONS | |
NO20005913L (en) | Medicinal Composition | |
EE200000759A (en) | Pharmaceutical compositions for aerosols with two or more active ingredients | |
PT1242087E (en) | PHARMACEUTICAL COMPOSITIONS | |
MA26621A1 (en) | COMPOSITION FOR PHARMACEUTICAL AEROSOLS | |
ID29262A (en) | PHARMACEUTICAL COMPOSITION | |
GB9827996D0 (en) | Pharmaceutical Compositions | |
DK1128831T3 (en) | Pharmaceutical moxifloxacin preparation | |
ID22562A (en) | COMPOSITION FOR DANGEROUS ARTROPODA | |
ID27201A (en) | PHARMACEUTICAL COMPOSITION | |
DE69928344D1 (en) | Pharmaceutical implant | |
HUP0203648A3 (en) | Pharmaceutical compositions for ulcer | |
GB9809213D0 (en) | Pharmaceutical compositions | |
PT1239832E (en) | PHARMACEUTICAL COMPOSITIONS | |
NO995851D0 (en) | Preparation process for isoxazolidinedione compound | |
ID30032A (en) | PHARMACEUTICAL FORMULATION | |
PT941100E (en) | PHARMACEUTICAL COMPOSITIONS | |
FI4488U1 (en) | Pharmaceutical composition | |
EE200000330A (en) | Pharmaceutical compositions | |
FI981337A0 (en) | Method for preparing virus-safe pharmaceutical compositions | |
EE200000459A (en) | Pharmaceutical compositions | |
GB9806487D0 (en) | Pharmaceutical compositions | |
IT1273613B (en) | HETEROCYCLIC COMPOUNDS, PHARMACEUTICAL COMPOSITIONS THAT INCLUDE THEM AND PROCEDURE FOR THEIR PREPARATION | |
FI981567A0 (en) | Pharmaceutical compositions |